|
|
 |
|
Viewing report
|
|
|
|
Wyeth: Company Analysis
RocSearch Ltd, March 2006, Pages: 44
The global pharmaceutical industry is faced with the challenge of ensuring the viability of its high-cost, high-margin, blockbuster drugs-based business model. Wyeth, headquartered in New Jersey, has business interests in pharmaceuticals, consumer healthcare and animal healthcare products. The company has a diverse product portfolio and strong revenue-generating brands.
The report starts with a historical overview of Wyeth and then goes on to describe the company’s organization structure and its three business lines. The company has also been examined critically within the SWOT framework. A brief study of the global pharma industry landscape, including the major players, follows.
The report also includes a summary of Wyeth’s financials and a peer group comparison involving GlaxoSmithKline, Novartis, and Merck on some key indicators. The report concludes with an outlook on the company from the twin perspectives of the analysts and the company itself .
Customers who bought this item also bought
Wyeth
Company Analysis - Wyeth
Wyeth: Pharmavitae Profile 2005
Wyeth - SWOT Analysis
Wyeth: Performance, Products, Pipeline and Potential
Analysis of Wyeth
Wyeth - Financial and Strategic Analysis Review
Wyeth Ltd
Wyeth: key issues and metrics in Big Pharma
The Top 10 World's Leading Animal Health Companies: Fort Dodge/Wyeth
Wyeth: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market
Pharmaceuticals - Global Outlook
|
|
|
|
